SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001867096-24-000057
Filing Date
2024-04-23
Accepted
2024-04-23 16:32:21
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-23

Document Format Files

Seq Description Document Type Size
1 ARS a2023annualreport.pdf ARS 14448258
  Complete submission text file 0001867096-24-000057.txt   19904415
Mailing Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607
Business Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607 844-445-5704
Xeris Biopharma Holdings, Inc. (Filer) CIK: 0001867096 (see all company filings)

IRS No.: 871082097 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40880 | Film No.: 24865261
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)